α-Interferon retreatment of patients with chronic hepatitis C

American Journal of Gastroenterology

Volumn 91, Issue 8, 1996, Pages 1523-1526

  Rabinovitz, Mordechai ^a,b   Block, Geoffrey ^a   Finkelstein, Sydney D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; PRIORITY JOURNAL; RELAPSE; TREATMENT OUTCOME;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEPACIVIRUS; HEPATITIS C; HEPATITIS, CHRONIC; HUMANS; INTERFERON-ALPHA; LIVER; LIVER CIRRHOSIS; MALE; RECURRENCE; RNA, VIRAL; TIME FACTORS; TREATMENT FAILURE;

EID: 0029737718     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Davis GL, Balart LA, Schiff ER, et al. Treatment of chronic hepatitis C with recombinant interferon alpha: a multicenter randomized, controlled trial. N Engl J Med 1989;321:1501-6.
2. Di Bisceglie AM, Martin P, Kassianides C, et al. Recombinant interferon alpha therapy for chronic hepatitis C: A randomized, double-blind, placebo-controlled trial. N Engl J Med 1989;321:1506-10.
3. Saez-Royuela F, Porres JC, Moreno A, et al. High doses of recombinant α-interferon or γ-interferon for chronic hepatitis C: A randomized controlled trial. Hepatology 1991;13:327-31.
4. Alberti A, Chemello L, Bonetti P, et al. Treatment with interferon(s) of community-acquired chronic hepatitis and cirrhosis type C. J Hepatol 1993; 17(Suppl:3):S123-6.
5. Bosch O, Tapia L, Quiroga JA, et al. An escalating dose regime of recombinant interferon-alpha 2A in the treatment of chronic hepatitis C. J Hepatol 1993;17:146-9.
6. Poynard T, Bedossa P, Chevallier M, et al. A comparison of three interferon alfa-2b regimens for the long term treatment of chronic non-A, non-B hepatitis. N Engl J Med 1995;332:1457-62.
7. Reichard O, Foberg U, Fryden A, et al. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks. Hepatology 1994;19:280-5.
8. Picciotto A, Varagona G, Valle F, et al. Interferon therapy in chronic hepatitis C. Evaluation of a low dose maintenance schedule in responder patients. J Hepatol 1993;17:359-63.
9. Marcellin P, Boyer N, Pouteau M, et al. Retreatment with interferon-α of chronic hepatitis C virus infection. Lancet 1994;344:690-1.
10. Pardo M, Cotonat T, Herrero M, et al. Retreatment of chronic hepatitis C virus infection. Lancet 1994;343:1568-9.
11. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histologic activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
12. Marcellin P, Pouteau M, Boyer N, et al. Retreatment with recombinant interferon-α in patients with chronic hepatitis C. J infect Dis 1993; 167:780-1.
13. Toyoda H, Nakano S, Takeda I, et al. Retreatment of chronic hepatitis C with interferon. Am J Gastroenterol 1994;89:1453-7.
14. Weiland O, Zhang Y-Y, Widell A. Serum HCV RNA levels in patients with chronic hepatitis C given a second course of interferon alpha-2b treatment after relapse following initial treatment. Scand J Infect Dis 1993;25:25-30.
15. Schvarcz R, Glaumann H, Weiland O, et al. Interferon alpha-2b treatment of chronic post-transfusion non-A, non-B/C hepatitis: Long-term outcome and effect of increased interferon doses in non-responders. Scand J Infect Dis 1991;23:413-20.
16. Marriott E, Quiroga JA, Carreno V. Retreatment of chronic hepatitis C with interferon-α. J Infect Dis 1992;166:1200-1.